Porton Newsletter - September 2025 Recap

Others

News 2025-09-28

Porton Shanghai Pudong Facility Obtained ISO 14001 and ISO 45001 Certification

Porton Pharma's Shanghai Pudong site successfully obtained ISO 14001 and ISO 45001 certifications, enhancing sustainable operations and CDMO capabilities for biotech clients.

News 2025-09-25

Porton Pharma Makes China's Innovative Pharmaceuticals Decennial Honor Roll, Secures 'Industry-Leading CDMO' Title

Porton Pharma honored as Industry Leading CDMO Company for innovative drug development services. Learn more about our award and global capabilities.

Become part of Porton's community to access personalized insights and resources.

First name *

Last name *

E-mail *

Company *

Subscribe for the Newsletter

Porton requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and our commitment to protecting your privacy, please review our Legal Disclaimer Terms and Porton Privacy.

US: (609) 860-1300
CN: (86) 23-8608-3200

This website provides information on products tailored for a diverse audience and may include product details or information that are not readily accessible or valid in your country. Please note that we do not accept any responsibility for accessing such information in a manner that may violate any legal processes, regulations, registrations, or usage guidelines in your country of origin.

Become part of Porton's community to access personalized insights and resources.

Submit

By clicking “Submit” you agree to our Legal Disclaimer terms and conditions and the Porton Privacy and Cookies Policy.

US: (609) 860-1300
CN: (86) 23-8608-3200